Your browser doesn't support javascript.
loading
[Updates on rickets and osteomalacia: FGF23-mediated hypophosphatemic rickets/osteomalacia].
Michigami, Toshimi.
Afiliação
  • Michigami T; Department of Bone and Mineral Research, Osaka Medical Center and Research Institute for Maternal and Child Health, Japan.
Clin Calcium ; 23(10): 1429-35, 2013 Oct.
Article em Ja | MEDLINE | ID: mdl-24076640
ABSTRACT
Some of the hypophosphatemic rickets/osteomalacia are caused by the increased bioactivity of FGF23, and classified into FGF23-mediated hypophosphatemic rickets/osteomalacia. This group includes various disorders such as X-linked, autosomal dominant and autosomal recessive hypophosphatemic rickets/osteomalacia, tumor-induced osteomalacia, and rickets/osteomalacia caused by the administration of iron polymaltose or saccharated ferric oxide. Measurement of serum levels of FGF23 is useful for diagnosis of these conditions. In the adult patients with FGF23-mediated hypophosphatemic rickets/osteomalacia, mineralizing enthesoopathy is an often observed complication.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteomalacia / Fatores de Crescimento de Fibroblastos / Raquitismo Hipofosfatêmico Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: Ja Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteomalacia / Fatores de Crescimento de Fibroblastos / Raquitismo Hipofosfatêmico Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: Ja Ano de publicação: 2013 Tipo de documento: Article